Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... of cancer, promoting sustained activation and proliferation of gene-modified antitumor T cells." Altvater and colleagues published their study in Cancer ...
2009 NOV 23 ... listeriolysin-O (LLO) and a model tumor antigen have been shown to exert strong antitumor activity. The aim of this study is to extend these observations to a self-protein and ...
2009 NOV 23 ... and colleagues published their study in Molecular Pharmaceutics (Synthesis and In Vivo Antitumor Efficacy of PEGylated Poly(L-lysine) Dendrimer-Camptothecin Conjugates. Molecular ...
2009 NOV 23 ... there is a plethora of reports evaluating the effect of immunotherapy in stimulating antitumor immune responses, the majority of these studies do not pay attention to the effect aging ...
2009 NOV 29 ... for Medical Genetics, Ghent University Hospital in Belgium, and colleagues evaluated the antitumor efficacy of nutlin-3, a potent and selective antagonist of the p53-MDM2 ...
2009 NOV 23 ... Nano report."The resulting nanoparticle, HFT-T, is expected to retain the antitumor activity of paclitaxel and specifically target folate receptor (FR)-expressing tumors, ...
2009 NOV 23 ... "Regulatory T (Treg) cells represent a major roadblock to the induction of antitumor immunity through vaccine approaches. TGF-beta is a cytokine implicated in the generation ...
2009 NOV 25 ... confirmed that EC0305 is the most favorable conjugate of the group due to its potent antitumor activity [100% cures at 1 mu mol/kg, three times a week (TIW) for 2 weeks] and its ...
2009 NOV 23 ... their study in Cancer Immunology Immunotherapy (Mechanisms of murine dendritic cell antitumor dysfunction in aging. Cancer Immunology Immunotherapy, 2009;58(12):1935-1939). ...
2009 NOV 23 ... "In this paper we analyzed the influence of two mechanistically diverse antitumor agents-cisplatin and methotrexate on the proliferation and cell cycle of two head and ...
2009 NOV 17 ... intracellular copper homeostasis. hCtr1 is involved in the transport of platinum-based antitumor agents such as cisplatin (CDDP); however, the mechanisms that regulate hCtr1-mediated ...
2009 NOV 23 ... DCs matured in the presence of Toxoplasma gondii components induce a potent antitumor response in a mouse model of fibrosarcoma. Bone-marrow derived DCs (BMDCs) were cultured ...
2009 NOV 23 ... Researchers detail in 'The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma,' new data in ovarian cancer. ...
2009 NOV 23 ... Recent findings The number of reports of immune-mediated neuropathies associated with antitumor necrosis factor alpha (anti-TNF alpha) therapy is increasing," scientists in Osaka, ...
2009 NOV 23 ... may aid the exploration of new therapeutic strategies to potentiate antimicrobial and antitumor immunity. J. Leukoc. Biol. 86: 941-948; 2009." Presicce and colleagues ...
2009 NOV 17 ... and bovine gelatin (Gel) can be used as an intravascular contrast agent at MRI and as an antitumor cell proliferation agent in vitro. We injected Gd-DTPA-Gel-Cis (200 mg/mL) into the ...
2009 NOV 23 ... their study in Brazilian Journal of Medical and Biological Research (Synergistic antitumor effect of TRAIL and adriamycin on the human breast cancer cell line MCF-7. Brazilian ...
